We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$13.2M
2
TSLA icon
Tesla
TSLA
+$12.9M
3
BIDU icon
Baidu
BIDU
+$11.9M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10M
5
AMED
Amedisys
AMED
+$8.89M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TDW icon
1376
Tidewater
TDW
$4.12B
– –
-6,219
Closed -$287K
TEAM icon
1377
Atlassian
TEAM
$37.8B
– –
-1,626
Closed -$330K
TECH icon
1378
Bio-Techne
TECH
$11.3B
– –
-9,530
Closed -$490K
TECK icon
1379
Teck Resources
TECK
$32.6B
– –
-83,824
Closed -$3.38M
TEL icon
1380
TE Connectivity
TEL
$62.6B
– –
-1,946
Closed -$328K
TENB icon
1381
Tenable Holdings
TENB
$4.01B
– –
-9,865
Closed -$333K
TGI
1382
DELISTED
Triumph Group
TGI
– –
-29,731
Closed -$766K
THRD
1383
DELISTED
Third Harmonic Bio
THRD
– –
-76,822
Closed -$417K
TIGR
1384
UP Fintech Holding
TIGR
$861M
– –
-20,000
Closed -$193K
TIXT
1385
DELISTED
TELUS International
TIXT
– –
-15,982
Closed -$58K
TMF icon
1386
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
$2.18B
– –
-7,430
Closed -$292K
TMUS icon
1387
T-Mobile US
TMUS
$190B
– –
-1,279
Closed -$305K
TPL icon
1388
Texas Pacific Land
TPL
$23.5B
– –
-573
Closed -$202K
TRUE
1389
DELISTED
TrueCar
TRUE
– –
-300,000
Closed -$570K
TTC icon
1390
Toro Company
TTC
$9.49B
– –
-4,300
Closed -$304K
TTD icon
1391
Trade Desk
TTD
$6.49B
– –
-16,400
Closed -$1.18M
UAMY icon
1392
United States Antimony
UAMY
$1.02B
– –
-12,100
Closed -$26.4K
UDR icon
1393
UDR
UDR
$12.3B
– –
-7,330
Closed -$299K
UNH icon
1394
UnitedHealth
UNH
$370B
– –
-2,906
Closed -$907K
UPST icon
1395
Upstart Holdings
UPST
$3.03B
– –
-4,465
Closed -$289K
USLM icon
1396
United States Lime & Minerals
USLM
$3.44B
– –
-2,229
Closed -$222K
VCEL icon
1397
Vericel Corp
VCEL
$2.31B
– –
-7,420
Closed -$316K
VERV
1398
DELISTED
Verve Therapeutics
VERV
– –
-30,718
Closed -$345K
VGSH icon
1399
Vanguard Short-Term Treasury ETF
VGSH
$30.2B
– –
-8,220
Closed -$483K
VIGL
1400
DELISTED
Vigil Neuroscience
VIGL
– –
-118,568
Closed -$943K
54 55
56
57 58

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.